Sponsors (2)
The bill increases consumer safety and transparency by allowing revocation of dubious pre-2000 GRAS approvals and adding publication requirements, but it imposes compliance costs and potential market disruptions for manufacturers and may introduce governance concerns about conflicts of interest.
Consumers are more likely to be protected from potentially unsafe food substances because the bill allows revocation of pre-2000 GRAS designations that lack demonstrated safety.
Taxpayers and the public gain greater transparency because the review Board must publish review results and notify Congress within set deadlines.
Food manufacturers receive a clearer, fair process (including 180 days to submit scientific evidence) before any GRAS revocation, preserving due process for businesses.
Food manufacturers face new compliance costs and risk civil penalties or having substances treated as unapproved additives if they fail to notify or meet deadlines.
Consumers could see higher prices or reduced product availability if revocations lead to recalls or removal of certain food products from the market.
Adding unpaid government, industry, and academic members to the Board may raise risks of conflicts of interest or under-resourcing that could undermine thorough, unbiased reviews.
Based on analysis of 2 sections of legislative text.
Creates an FDA-led Board to review pre-2000 manufacturer-attributable GRAS designations, require manufacturer disclosure, and enable revocation when safety is not demonstrated.
Official title: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to establish a board to review certain designations that a substance used in food is generally recognized as safe, with respect to the intended use of such substance, and for other purposes.
Introduced January 30, 2026 by Michael Lawler · Last progress January 30, 2026
Creates a GRAS (Generally Recognized as Safe) Review Board at HHS/FDA to identify, review, and potentially revoke manufacturer-attributable GRAS designations made before 2000. The Board must categorize pre-2000 GRAS designations, require manufacturers to disclose which pre-2000 designations they are attributable for, review safety evidence, report findings publicly, and recommend revocations when safety is not demonstrated. The Board has multi-agency membership (HHS, FDA, USDA, EPA, plus academic and industry representatives), will notify the Secretary and Congress when a pre-2000 GRAS lacks demonstrated safety, and triggers a Secretary-led process for potential revocation, compliance orders, recalls, and enforcement. The Board sunsets ten years after enactment; manufacturers face deadlines and potential civil penalties for noncompliance.